ArticleMedComm2026

Inhibition of FOS-Like Antigen 1 Reduces Chemoresistance to Temozolomide Through Stemness Reprogramming via IL-6/STAT3

JeongMin Sim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.